Cargando…
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150
Autores principales: | Cadiou, Simon, Perdriger, Aleth, Ardois, Samuel, Albert, Jean-David, Berthoud, Olivia, Lescoat, Alain, Guggenbuhl, Pascal, Robin, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de rhumatologie.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480145/ https://www.ncbi.nlm.nih.gov/pubmed/34600148 http://dx.doi.org/10.1016/j.jbspin.2021.105282 |
Ejemplares similares
-
Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021) -
Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969) -
Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021) -
An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022) -
Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)